Nitrosation of CD36 regulates endothelial function and serum lipids

Melissa A. Luse,Wyatt J. Schug,Luke S. Dunaway,Shruthi Nyshadham,Skylar A. Loeb,Alicia Carvalho,Rachel Tessema,Caitlin Pavelic,T.C. Stevenson Keller IV,Xiaohong Shu,Claire A. Ruddiman,Anna Kosmach,Timothy M. Sveeggen,Ray Mitchell,Pooneh Bagher,Richard D. Minshall,Norbert Leitnger,Linda Columbus,Kandice R. Levental,Ilya Levental,Miriam Cortese-Krott,Brant E. Isakson

DOI: https://doi.org/10.1101/2024.04.09.588733

2024-04-09

Abstract:During obesity, endothelial cells (ECs) become lipid laden leading to endothelial dysfunction. We demonstrate endothelium downregulates caveolin-1 (Cav1) in mouse and human in response to obesity. Using an EC-specific Cav1 knockout mouse, we find mice are hyperlipidemic regardless of diet, but retain endothelial cell function. Whereas initially this was thought to be due to Cav1 mediate endocytosis, we find instead the mice have significantly increased nitric oxide (NO) in response to the lack of Cav1. The presence or absence of NO toggled inversely EC lipid content and plasma lipid in mice. We found the fatty acid translocase CD36 was directly nitrosated by endogenous NO at the same cysteines that are palmitoylated on CD36. The nitrosation of CD36 prevented it’s trafficking to the plasma membrane and decreased lipid uptake. The physiological effect of this mechanism was a reliance on NO for endothelial function. This work suggests that CD36 nitrosation occurs as a protective mechanism to prevent EC lipotoxicity and preserve function.

Molecular Biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how endothelial cells (ECs) control lipid accumulation by regulating the nitration of CD36 under obese conditions, thereby preventing lipotoxicity and maintaining their functions. Specifically, the study explored how the decreased expression of Caveolin - 1 (Cav1) in endothelial cells affects the lipid - handling mechanism in the context of metabolic syndrome, as well as the regulatory role of nitric oxide (NO) on CD36 through nitration. The study revealed a new mechanism in which NO prevents CD36 from localizing to the cell membrane by nitrating specific cysteine sites on CD36, thereby reducing lipid uptake and protecting endothelial cells from lipotoxic damage.

### Key findings:
1. **Changes in Cav1 expression in obesity**: The study found that in mice and humans, obesity leads to a decrease in Cav1 expression in adipose tissue endothelial cells.
2. **Effects of Cav1 deficiency**: After specifically knocking out Cav1 in endothelial cells, mice showed hyperlipidemia, but endothelial cell function remained normal.
3. **Role of NO**: Cav1 deficiency leads to an increase in NO levels, and NO prevents its localization to the cell membrane by nitrating specific cysteine sites (C3 and C466) on CD36, thereby reducing lipid uptake.
4. **Nitration of CD36 and lipid uptake**: By mutating the key cysteine sites on CD36, the study confirmed the inhibitory effect of nitration at these sites on lipid uptake.
5. **Physiological significance**: NO not only reduces lipid accumulation in endothelial cells but also increases plasma lipid levels by regulating the nitration of CD36, thereby protecting endothelial cells from lipotoxic damage.

### Significance of the study:
This study revealed a new mechanism by which NO regulates lipid uptake by nitrating CD36, providing a new perspective for understanding endothelial cell dysfunction under metabolic syndrome and obese conditions. This finding may provide a theoretical basis for the development of new treatment strategies for lipid metabolism disorders and cardiovascular diseases.